Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental Inflammation

NCT05197387 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 322

Last updated 2024-10-16

No results posted yet for this study

Summary

This observational prospective study will help to determine if an immune process similar to allograft rejection is responsible for the occurrence of an intrahepatic cholestasis of pregnancy (ICP).

If so, it would suggest the potential benefit of immunomodulatory therapeutics.

Conditions

  • Cholestasis of Pregnancy

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2025-06-21
Completion
2025-06-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05197387 on ClinicalTrials.gov